Jeffrey H. Buchalter
2006
In 2006, Jeffrey H. Buchalter earned a total compensation of $3.8M as Chairman of the Board, President and Chief Executive Officer at Enzon Pharmaceuticals.
Compensation breakdown
Non-Equity Incentive Plan | $1,050,000 |
---|---|
Option Awards | $1,385,352 |
Salary | $672,115 |
Stock Awards | $624,094 |
Other | $72,145 |
Total | $3,803,706 |
Buchalter received $1.4M in option awards, accounting for 36% of the total pay in 2006.
Buchalter also received $1.1M in non-equity incentive plan, $672.1K in salary, $624.1K in stock awards and $72.1K in other compensation.
Rankings
In 2006, Jeffrey H. Buchalter's compensation ranked 843rd out of 7,022 executives tracked by ExecPay. In other words, Buchalter earned more than 88.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 843 out of 7,022 | 88th |
Division Manufacturing | 261 out of 2,413 | 89th |
Major group Chemicals And Allied Products | 47 out of 673 | 93rd |
Industry group Drugs | 28 out of 518 | 95th |
Industry Biological Products, Except Diagnostic Substances | 4 out of 112 | 96th |
Source: SEC filing on April 16, 2008.
Buchalter's colleagues
We found four more compensation records of executives who worked with Jeffrey H. Buchalter at Enzon Pharmaceuticals in 2006.
2006
Ivan Horak
Enzon Pharmaceuticals
Chief Scientific Officer
2006
Craig Tooman
Enzon Pharmaceuticals
Chief Financial Officer
2006
Ralph del Campo
Enzon Pharmaceuticals
Executive Vice President, Technical Operations
2006
Paul Davit
Enzon Pharmaceuticals